产品名称 | NebuSelect™ Recombinant Human IGFBP2, His-tag |
---|---|
目录号 | NBL-242525 |
别名 | IGFBP2; IBP-2; IGFBP-2; BP2; AI255832; mIGFBP-2; IGFBP2; IGF-BP53 |
外观 | see COA |
分子量 | Ala36-Gln325 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P18065 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242525-100ug | 100ug | Inquire | Inquire | |
NBL-242525-1mg | 1mg | Inquire | Inquire | |
NBL-242525-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human IGFBP2, His-tag
Catalog#:
NBL-242525
Description:
NebuSelect™ Recombinant Human IGFBP2, His-tag(Cat#NBL-242525) is expressed in HEK293 with His tag at the C-Terminus.It contains Ala36-Gln325.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 32.5 kDa. Due to glycosylation, the protein migrates to 33-40 kDa based on Bis-Tris PAGE result.
Target Name:
IGFBP2; IBP-2; IGFBP-2; BP2; AI255832; mIGFBP-2; IGFBP2; IGF-BP53
Target Information:
Insulin-like growth factor (IGF) binding protein 2 (IGFBP2) was discovered and identified as an IGF system regulator, controlling the distribution, function, and activity of IGFs in the pericellular space. IGFBP2 is a developmentally regulated gene that is highly expressed in embryonic and fetal tissues and markedly decreases after birth. Aberrant expression of IGFBP2 in cancer acts as a hub of an oncogenic network, integrating multiple cancer signaling pathways and serving as a potential therapeutic target for cancer treatment.
Amino Acid Sequence:
Ala36-Gln325
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.